Emerging medications versus phentermine The next generation of GLP-1 based medications will make the comparison with phentermine even more lopsided
No - 10016026000919 (FSSAI)
doi: 10.1016/j.tibs.2009.02.004
The composition according to Claim 1, wherein the surfactant is chosen from a combination of one or more polymer bases, for example glycerol, glycerine, sortibal aloe, polyglycols, polyethylene glycol, polyoxyethylene and polyethylene oxide in combination with ethoxylated partial glyceride fatty acid esters, branched chain esters, protein derivatives, lanolin and lanolin derivatives, and fatty alcohol ethoxylates, emollient oils, fatty acids, fatty alcohols and their esters
Topical Finasteride (0.25%): At 100200 L scalp DHT ~4752%, systemic ~24%